Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation
- PMID: 33329844
- PMCID: PMC7724119
- DOI: 10.17085/apm.19067
Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation
Abstract
Background: Lightwand is a convenient tool that can be used instead of a laryngoscope for intubation. Tracheal intubation causes direct stimulation of the larynx, drastically increasing hemodynamic values including blood pressure and heart rate. This study aims to identify the effect of different doses of esmolol on hemodynamic changes during lightwand intubation.
Methods: The study subjects included 140 patients who underwent general anesthesia for elective surgery. The patients were randomly divided into four groups (35 patients in each group). The 'C' group only received 20 ml of normal saline, while the 'E0.5', 'E1', and 'E2' groups received 20 ml of normal saline containing esmolol-0.5 mg/kg, 1 mg/kg, and 2 mg/kg, respectively, injected 2 min prior to intubation. The patients' blood pressure, heart rate, and rate-pressure product were measured six times, before and after the intubation.
Results: The degree of heart rate elevation was suppressed in the E1 and E2 groups compared to the C group, and RPP after intubation significantly decreased in the E2 group compared to the C group.
Conclusions: Esmolol injection, 1-2 mg/kg, prior to lightwand intubation effectively blunts heart rate elevation, and 2 mg/kg of esmolol injection blunts rate-pressure product elevation.
Keywords: Blood pressure; Esmolol; Heart rate; Intubation; Lightwand; Rate pressure product.
Copyright © the Korean Society of Anesthesiologists, 2020.
Conflict of interest statement
CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported.
Figures






Similar articles
-
Comparison of esmolol and lidocaine for attenuation of cardiovascular stress response to laryngoscopy and endotracheal intubation in a Ghanaian population.Anesth Essays Res. 2013 Jan-Apr;7(1):83-8. doi: 10.4103/0259-1162.114008. Anesth Essays Res. 2013. PMID: 25885726 Free PMC article.
-
Effects of intravenous lidocaine and/or esmolol on hemodynamic responses to laryngoscopy and intubation: a double-blind, controlled clinical trial.J Clin Anesth. 1996 Sep;8(6):491-6. doi: 10.1016/0952-8180(96)00109-2. J Clin Anesth. 1996. PMID: 8872690 Clinical Trial.
-
Hemodynamic responses to tracheal intubation with laryngoscope versus lightwand intubating device (Trachlight) in adults with normal airway.Anesth Analg. 2002 Aug;95(2):480-4, table of contents. doi: 10.1097/00000539-200208000-00046. Anesth Analg. 2002. PMID: 12145076 Clinical Trial.
-
Comparison of Esmolol and Dexmedetomidine for Suppression of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation in Adult Patients Undergoing Elective General Surgery: A Prospective, Randomized Controlled Double-blinded Study.Anesth Essays Res. 2018 Jan-Mar;12(1):262-266. doi: 10.4103/aer.AER_226_17. Anesth Essays Res. 2018. PMID: 29628593 Free PMC article.
-
Comparison of Intravenous Dexmedetomidine versus Esmolol for Attenuation of Hemodynamic Response to Tracheal Intubation after Rapid Sequence Induction: A Systematic Review and Meta-Analysis.Biomed Res Int. 2019 Apr 17;2019:6791971. doi: 10.1155/2019/6791971. eCollection 2019. Biomed Res Int. 2019. PMID: 31139645 Free PMC article.
References
-
- Prys-Roberts C, Greene LT, Meloche R, Foëx P. Studies of anaesthesia in relation to hypertension. II. Haemodynamic consequences of induction and endotracheal intubation. Br J Anaesth. 1971;43:531–47. - PubMed
-
- Kanaide M, Fukusaki M, Tamura S, Takada M, Miyako M, Sumikawa K. Hemodynamic and catecholamine responses during tracheal intubation using a lightwand device (Trachlight) in elderly patients with hypertension. J Anesth. 2003;17:161–5. - PubMed
-
- Davis L, Cook-Sather SD, Schreiner MS. Lighted stylet tracheal intubation: a review. Anesth Analg. 2000;90:745–56. - PubMed
-
- Sintetos AL, Hulse J, Pritchett EL. Pharmacokinetics and pharmacodynamics of esmolol administered as an intravenous bolus. Clin Pharmacol Ther. 1987;41:112–7. - PubMed
-
- Wiest D. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics. Clin Pharmacokinet. 1995;28:190–202. - PubMed
LinkOut - more resources
Full Text Sources
Medical